C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy

Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy

(2011) Camilla Jandus et al.   BIOCHEMICAL PHARMACOLOGY

Supramolecular Complexing of Membane Siglec CD22 Mediated by a Polyvalent Heterobifunctional Ligand that Templates on IgM

(2011) Lina Cui et al.   BIOCONJUGATE CHEMISTRY

CD22-Antagonists with nanomolar potency: The synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold

(2011) Hajjaj H.M. Abdu-Allah et al.   BIOORGANIC & MEDICINAL CHEMISTRY

From a Library of MAG Antagonists to Nanomolar CD22 Ligands

(2011) Stefanie Mesch et al.   ChemMedChem

Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22

(2011) Weihsu C. Chen et al.   LEUKEMIA & LYMPHOMA

A Fragment-Based In Situ Combinatorial Approach To Identify High-Affinity Ligands for Unknown Binding Sites

(2010) Sachin V. Shelke et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

In vivo targeting of B-cell lymphoma with glycan ligands of CD22

(2010) W. C. Chen et al.   BLOOD

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Kinetic and thermodynamic properties of MAG antagonists

(2010) Stefanie Mesch et al.   CARBOHYDRATE RESEARCH

Design, Synthesis, and Structure−Affinity Relationships of Novel Series of Sialosides as CD22-Specific Inhibitors

(2008) Hajjaj H. M. Abdu-Allah et al.   JOURNAL OF MEDICINAL CHEMISTRY

Sialic acid dependence in rotavirus host cell invasion

(2008) Thomas Haselhorst et al.   Nature Chemical Biology